Illumina Inc ILMN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/23/22 EDT
190.38UNCH (UNCH)
Volume
21,657
Close
190.38quote price arrow down-3.11 (-1.61%)
Volume
1,298,061
52 week range
173.45 - 436.95
Loading...
  • Open193.04
  • Day High194.46
  • Day Low188.42
  • Prev Close193.49
  • 52 Week High436.95
  • 52 Week High Date09/24/21
  • 52 Week Low173.45
  • 52 Week Low Date07/14/22

Key Stats

  • Market Cap29.909B
  • Shares Out157.10M
  • 10 Day Average Volume1.43M
  • Dividend-
  • Dividend Yield-
  • Beta1.15
  • YTD % Change-49.96

KEY STATS

  • Open193.04
  • Day High194.46
  • Day Low188.42
  • Prev Close193.49
  • 52 Week High436.95
  • 52 Week High Date09/24/21
  • 52 Week Low173.45
  • 52 Week Low Date07/14/22
  • Market Cap29.909B
  • Shares Out157.10M
  • 10 Day Average Volume1.43M
  • Dividend-
  • Dividend Yield-
  • Beta1.15
  • YTD % Change-49.96

RATIOS/PROFITABILITY

  • EPS (TTM)-0.08
  • P/E (TTM)-2,335.95
  • Fwd P/E (NTM)60.77
  • EBITDA (TTM)49.00M
  • ROE (TTM)-0.26%
  • Revenue (TTM)4.692B
  • Gross Margin (TTM)67.54%
  • Net Margin (TTM)-0.43%
  • Debt To Equity (MRQ)16.66%

EVENTS

  • Earnings Date11/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

Final Trades: Uber, Illumina, Goldman Sachs & more
VIDEO2:0202:02
Final Trades: Uber, Illumina, Goldman Sachs & more

Profile

MORE
Illumina, Inc. is a provider of sequencing- and array-based solutions for genetic and genomic analysis. The Company operates through two segments: Core Illumina and GRAIL. Core Illumina products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. GRAIL is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated sequencing and microarray systems...
John Thompson
Independent Chairman of the Board
Francis deSouza
President, Chief Executive Officer, Director
Alex Aravanis M.D., Ph.D.
Chief Technology Officer, Head of Research and Product Development
Carissa Rollins
Chief Information Officer
Charles Dadswell
General Counsel, Secretary
Address
5200 Illumina Way
San Diego, CA
92122-4616
United States

Top Peers

SYMBOLLASTCHG%CHG
GMAB
Genmab A/S
31.83-1.51-4.53%
ALNY
Alnylam Pharmaceuticals Inc
200.78-1.93-0.95%
BIIB
Biogen Inc
197.78-2.84-1.42%
INCY
Incyte Corp
66.89-0.52-0.77%
CRL
Charles River Laboratories International Inc
187.51+2.68+1.45%